Regeneron Pharmaceuticals said earlier this month that it will acquire “substantially all” of 23andMe’s assets for $256 million.
Related Posts
Musk, X to face trial in Don Lemon lawsuit alleging breach of contract
Musk and X have faced other lawsuits over non-payment to vendors and over failure to provide severance as promised to laid-off employees from Twitter.
With market rout, now is the time to rebalance portfolios and buy stocks, says Wells Fargo
Investors may be fleeing stocks for bonds, but they should be mindful of their portfolio allocations, said Wells Fargo’s Brian Rehling.
Santoli’s Monday market notes: Dip-buying impulse intact, meme stocks reenergized
Mike Santoli breaks down how the dip-buying impulse remains intact in today’s market notes.